Joachim F.
- Country
- Germany
- Department
- Klinik für Innere Medizin 3
Research Overview
- Evaluation of Reduced-Dose Alteplase in Intermediate-High-Risk Acute Pulmonary Embolism: A Randomized Controlled Trial
- Long-term Safety and Efficacy Evaluation of Oral BI 1015550 in Patients with Idiopathic and Progressive Pulmonary Fibrosis
- Efficacy and Safety Evaluation of BI 1015550 in Progressive Fibrosing Interstitial Lung Diseases: A Double-Blind, Randomized, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 101 of 264 partner sites.
Specializations
Pulmonary Fibrosis Research
Specializes in investigating therapeutic approaches for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), with particular emphasis on innovative treatment modalities.
- Long-term disease management strategies
- Treatment tolerability assessment
- Disease progression monitoring
Focuses on evaluating lung function parameters and developing sustained therapeutic interventions for fibrotic lung conditions.
Interstitial Lung Disease Studies
Conducts research in Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs), examining novel therapeutic approaches to improve lung function and patient outcomes.
- Lung function preservation
- Disease progression assessment
- Treatment efficacy evaluation
Specializes in evaluating therapeutic interventions aimed at reducing lung function decline in progressive fibrosing conditions.
Pulmonary Embolism Treatment
Investigates treatment approaches for intermediate-high-risk acute pulmonary embolism, with specific focus on optimizing thrombolytic therapy protocols.
- Thrombolytic treatment optimization
- Acute care management
- Risk-stratified therapeutic approaches
Explores innovative dosing strategies for thrombolytic treatments in pulmonary embolism care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.